DK1718673T3 - Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det - Google Patents

Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det

Info

Publication number
DK1718673T3
DK1718673T3 DK05731028T DK05731028T DK1718673T3 DK 1718673 T3 DK1718673 T3 DK 1718673T3 DK 05731028 T DK05731028 T DK 05731028T DK 05731028 T DK05731028 T DK 05731028T DK 1718673 T3 DK1718673 T3 DK 1718673T3
Authority
DK
Denmark
Prior art keywords
solution
composition
therapeutic use
use containing
nanofiltration step
Prior art date
Application number
DK05731028T
Other languages
English (en)
Inventor
Paul Boulange
Sami Chtourou
Stephane Boyer
Roland Schmitthaeusler
Bruno Padrazzi
Original Assignee
Fractionnement Et De Biotechno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34834103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1718673(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fractionnement Et De Biotechno filed Critical Fractionnement Et De Biotechno
Application granted granted Critical
Publication of DK1718673T3 publication Critical patent/DK1718673T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK05731028T 2004-02-27 2005-02-23 Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det DK1718673T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0402001A FR2866890B1 (fr) 2004-02-27 2004-02-27 Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
PCT/FR2005/000416 WO2005090402A1 (fr) 2004-02-27 2005-02-23 Procede de purificaton d’albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant

Publications (1)

Publication Number Publication Date
DK1718673T3 true DK1718673T3 (da) 2008-01-14

Family

ID=34834103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05731028T DK1718673T3 (da) 2004-02-27 2005-02-23 Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det

Country Status (16)

Country Link
US (3) US20070161122A1 (da)
EP (1) EP1718673B1 (da)
JP (2) JP4979571B2 (da)
AT (1) ATE373014T1 (da)
AU (1) AU2005223418B2 (da)
BR (1) BRPI0507886A (da)
CA (1) CA2557174C (da)
CY (1) CY1107082T1 (da)
DE (1) DE602005002461T2 (da)
DK (1) DK1718673T3 (da)
ES (1) ES2294696T3 (da)
FR (1) FR2866890B1 (da)
IL (1) IL177286A (da)
PL (1) PL1718673T3 (da)
PT (1) PT1718673E (da)
WO (1) WO2005090402A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
MY160298A (en) 2010-12-30 2017-02-28 Lab Francais Du Fractionnement Glycols as pathogen inactivating agents
FR3004451B1 (fr) * 2013-04-11 2015-12-11 Lab Francais Du Fractionnement Procede de preparation d'une solution de proteine c viralement securisee par une double etape de nanofiltration
US20180028593A1 (en) * 2014-03-21 2018-02-01 Boreal Invest Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregates
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique
CN115039180A (zh) * 2020-01-30 2022-09-09 费森尤斯医疗保健控股公司 用于透析毒素置换剂化合物的建模和优化技术
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019919D0 (en) 1990-09-12 1990-10-24 Delta Biotechnology Ltd Purification of proteins
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
US5440018A (en) 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JPH06279296A (ja) * 1993-03-25 1994-10-04 Asahi Chem Ind Co Ltd 血漿分画製剤中から蛋白質会合物の除去方法
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US6210683B1 (en) * 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
DE60121196T2 (de) * 2000-10-24 2007-07-12 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Verfahren zur monomerisierung von humanen serumalbumin-polymeren
US6806355B2 (en) * 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
US8258264B2 (en) 2003-04-09 2012-09-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing albumin preparation
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant

Also Published As

Publication number Publication date
EP1718673B1 (fr) 2007-09-12
JP4979571B2 (ja) 2012-07-18
JP2012102115A (ja) 2012-05-31
US20070161122A1 (en) 2007-07-12
PL1718673T3 (pl) 2008-03-31
BRPI0507886A (pt) 2007-08-07
ES2294696T3 (es) 2008-04-01
EP1718673A1 (fr) 2006-11-08
IL177286A0 (en) 2006-12-10
US9611311B2 (en) 2017-04-04
US20170166626A1 (en) 2017-06-15
CA2557174A1 (fr) 2005-09-29
US20150152162A1 (en) 2015-06-04
FR2866890A1 (fr) 2005-09-02
PT1718673E (pt) 2007-12-13
AU2005223418A1 (en) 2005-09-29
JP2007535495A (ja) 2007-12-06
FR2866890B1 (fr) 2008-04-04
IL177286A (en) 2012-08-30
DE602005002461T2 (de) 2008-06-12
CY1107082T1 (el) 2012-10-24
DE602005002461D1 (de) 2007-10-25
AU2005223418B2 (en) 2008-12-18
ATE373014T1 (de) 2007-09-15
CA2557174C (fr) 2013-04-30
WO2005090402A1 (fr) 2005-09-29
US10562957B2 (en) 2020-02-18

Similar Documents

Publication Publication Date Title
DK1718673T3 (da) Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det
EA200600014A1 (ru) Способ отгонки соводяным паром из газовых потоков
DE60228961D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
ATE331705T1 (de) Alpha-aminosäure-derivate, verfahren zu deren herstellung sowie deren verwendung als dipeptidylpeptidase-iv inhibitoren (dpp iv)
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
NO20050251L (no) Fremgangsmate for a rense Fischer-Tropsch-utvunnet vann
DK1409539T3 (da) Fremgangsmåde til fremstilling af en proteinholdig fraktion beriget med beta-TGF i aktiveret form, en proteinfraktion og terapeutiske anvendelser
DE602005020269D1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DK1301201T3 (da) Behandling af glycogenosis type II
EA200970294A1 (ru) Способ наращивания стволовых клеток взрослого организма из крови, в частности периферической, и соответственное применение в области медицины
MY146013A (en) Process for purifying mesotrione
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
DE60101575D1 (de) Verfahren zur herstellung von pharmazeutisch annehmbaren salzen des (ss,rs)-s-adenosyl-l-menthionin
ATE409075T1 (de) Niederdruckumkehrosmose- und nanofiltrationsmembranen und verfahren für ihre herstellung
ATE465998T1 (de) Verfahren zur herstellung und reinigung von 1,7'- dimethyl-2'-propyl-2,5'-bi-1h-benzimidazol
ATE428730T1 (de) Verfahren zur herstellung einer alpha-1- antitrypsinlösung
ATE247628T1 (de) Verfahren zur herstellung von gabapentin
TW200517368A (en) Process
ATE302749T1 (de) Verfahren zur herstellung von 5-aminosalicylsäure
DE50300920D1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
ATE457994T1 (de) Verfahren zur aufreinigung von vancomycin
ATE524430T1 (de) Verfahren zur aufreinigung von hexamethylendiamin
ATE322472T1 (de) 2-bromomethyl-6-methyl-benzoesäure und verfahren zu ihrer herstellung
DE602005018770D1 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolcarbonsäurederivaten